530 results on '"Gadina, Massimo"'
Search Results
2. Biallelic human SHARPIN loss of function induces autoinflammation and immunodeficiency
3. Variant STAT4 and Response to Ruxolitinib in an Autoinflammatory Syndrome
4. Protein kinases: drug targets for immunological disorders
5. Identification of Fibroinflammatory and Fibrotic Transcriptomic Subsets of Human Cutaneous Sclerotic Chronic Graft-Versus-Host Disease
6. JAK inhibitors: Is specificity at all relevant?
7. Author Correction: Protein kinases: drug targets for immunological disorders
8. Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease
9. Cytokines and Cytokine Receptors
10. List Of Contributors
11. Protein Kinase Antagonists
12. Cell Viability Multiplexing: Quantification of Cellular Viability by Barcode Flow Cytometry and Computational Analysis
13. A Multiomic Analysis to Identify Drivers of Subclinical Vascular Disease in Systemic Lupus Erythematosus.
14. Interrupting an IFN-γ-dependent feedback loop in the syndrome of pyogenic arthritis with pyoderma gangrenosum and acne.
15. Whole Chromosome Instability induces senescence and promotes SASP.
16. Homozygous variant p. Arg90His in NCF1 is associated with early-onset Interferonopathy: a case report
17. 3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine
18. Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus
19. Clonal haematopoiesis across the age spectrum of vasculitis patients with Takayasu's arteritis, ANCA-associated vasculitis and giant cell arteritis.
20. Clonal haematopoiesis across the age spectrum of vasculitis patients with Takayasu’s arteritis, ANCA-associated vasculitis and giant cell arteritis
21. Author Correction: Protein kinases: drug targets for immunological disorders
22. Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story
23. JAK Inhibitors: Is specificity at all relevant?
24. Divergent roles for STAT4 in shaping differentiation of cytotoxic ILC1 and NK cells during gut inflammation
25. Identification of Unique microRNA Profiles in Different Types of Idiopathic Inflammatory Myopathy
26. Critical Role for STAT4 Activation by Type 1 Interferons in the Interferon-γ Response to Viral Infection
27. STAT4 Serine Phosphorylation Is Critical for IL-12-Induced IFN-γ Production but not for Cell Proliferation
28. Cybr, A Cytokine-Inducible Protein That Binds Cytohesin-1 and Regulates Its Activity
29. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies
30. T-bet is Rapidly Induced by Interferon-γ in Lymphoid and Myeloid Cells
31. Cytokines and Cytokine Receptors
32. Protein Kinase Antagonists in Therapy of Immunological and Inflammatory Diseases
33. List of Contributors
34. IFN Consensus Sequence Binding Protein Potentiates STAT1-Dependent Activation of IFNγ -Responsive Promoters in Macrophages
35. Divergent roles for STAT4 in shaping effector differentiation of ILC1 and NK cells during gut inflammation
36. Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease
37. Biallelic human SHARPINloss of function induces autoinflammation and immunodeficiency
38. Editorial: JAK inhibition in autoimmune and inflammatory diseases
39. Identification of fibroinflammatory and fibrotic transcriptomic subsets of human sclerotic cutaneous chronic graft-versus-host disease
40. JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
41. Generation and differentiation of induced pluripotent stem cells reveal ankylosing spondylitis risk gene expression in bone progenitors
42. Human LUBAC deficiency leads to autoinflammation and immunodeficiency by dysregulation in TNF-mediated cell death
43. The JAK-STAT pathway at 30: Much learned, much more to do
44. Changes in cardiorespiratory function and fatigue following 12 weeks of exercise training in women with systemic lupus erythematosus: a pilot study
45. 85 - Protein Kinase Antagonists
46. 14 - Cytokines and Cytokine Receptors
47. 10 - Cytokines
48. Selective Janus kinase inhibitors come of age
49. Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy.
50. Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28–29 2017, Doha, Qatar)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.